160 related articles for article (PubMed ID: 29618864)
1. The conundrum of deep vein thrombosis prophylaxis in burns in India and review of literature.
Shirol SS; Kodaganur S; Rao MR; Tiwari V
Indian J Plast Surg; 2017; 50(3):288-294. PubMed ID: 29618864
[TBL] [Abstract][Full Text] [Related]
2. An analysis of deep vein thrombosis in burn patients (part II): A randomized and controlled study of thrombo-prophylaxis with low molecular weight heparin.
Ahuja RB; Bansal P; Pradhan GS; Subberwal M
Burns; 2016 Dec; 42(8):1693-1698. PubMed ID: 27633687
[TBL] [Abstract][Full Text] [Related]
3. Practice guidelines for deep venous thrombosis prophylaxis in burns.
Faucher LD; Conlon KM
J Burn Care Res; 2007; 28(5):661-3. PubMed ID: 17667344
[TBL] [Abstract][Full Text] [Related]
4. An analysis of deep vein thrombosis in burn patients (Part 1): Comparison of D-dimer and Doppler ultrasound as screening tools.
Ahuja RB; Bansal P; Pradhan GS; Subberwal M
Burns; 2016 Dec; 42(8):1686-1692. PubMed ID: 27639819
[TBL] [Abstract][Full Text] [Related]
5. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.
Perrotta C; Chahla J; Badariotti G; Ramos J
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD005259. PubMed ID: 35993965
[TBL] [Abstract][Full Text] [Related]
6. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
7. Risk of Deep vein thrombosis in neurosurgery: State of the art on prophylaxis protocols and best clinical practices.
Ganau M; Prisco L; Cebula H; Todeschi J; Abid H; Ligarotti G; Pop R; Proust F; Chibbaro S
J Clin Neurosci; 2017 Nov; 45():60-66. PubMed ID: 28890040
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors for deep vein thrombosis among pediatric burn patients.
Alturki N; Alkahtani M; Daghistani M; Alyafi T; Khairy S; Ashi M; Aljuffri A
Burns; 2019 May; 45(3):560-566. PubMed ID: 31018912
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological prophylaxis for deep vein thrombosis in acute spinal cord injury: an Indian perspective.
Halim TA; Chhabra HS; Arora M; Kumar S
Spinal Cord; 2014 Jul; 52(7):547-50. PubMed ID: 24819510
[TBL] [Abstract][Full Text] [Related]
10. Low-molecular-weight heparin prophylaxis of deep vein thrombosis for older patients with restricted mobility: propensity analyses of data from two multicentre, cross-sectional studies.
Labarère J; Sevestre MA; Belmin J; Legagneux A; Barrellier MT; Thiel H; Le Roux P; Pernod G; Bosson JL;
Drugs Aging; 2009; 26(3):263-71. PubMed ID: 19358621
[TBL] [Abstract][Full Text] [Related]
11. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
Bell GK; Goldhaber SZ
Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
[TBL] [Abstract][Full Text] [Related]
12. Low molecular weight heparin in prophylaxis of deep vein thrombosis in Asian general surgical patients: A Kashmir experience.
Dar TI; Wani KA; Ashraf M; Malik A; Ahmad S; Gojwari TA; Iqbal A
Indian J Crit Care Med; 2012 Apr; 16(2):71-4. PubMed ID: 22988360
[TBL] [Abstract][Full Text] [Related]
13. Practice patterns for deep vein thrombosis prophylaxis in minimal-access surgery.
Beekman R; Crowther M; Farrokhyar F; Birch DW
Can J Surg; 2006 Jun; 49(3):197-202. PubMed ID: 16749981
[TBL] [Abstract][Full Text] [Related]
14. What is the optimal prophylaxis against postoperative deep vein thrombosis in the living donor to avoid complications and enhance recovery? - A systematic review of the literature and expert panel recommendations.
Ruffolo LI; Levstik M; Boehly J; Spiro M; Raptis DA; Liu L; Hernandez-Alejandro R;
Clin Transplant; 2022 Oct; 36(10):e14688. PubMed ID: 35468241
[TBL] [Abstract][Full Text] [Related]
15. Thromboprophylaxis for trauma patients.
Barrera LM; Perel P; Ker K; Cirocchi R; Farinella E; Morales Uribe CH
Cochrane Database Syst Rev; 2013 Mar; (3):CD008303. PubMed ID: 23543562
[TBL] [Abstract][Full Text] [Related]
16. Home versus in-patient treatment for deep vein thrombosis.
Othieno R; Okpo E; Forster R
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD003076. PubMed ID: 29315455
[TBL] [Abstract][Full Text] [Related]
17. Risk factors of postoperative deep vein thrombosis (DVT) under low molecular weight heparin (LMWH) prophylaxis in patients with thoracolumbar fractures caused by high-energy injuries.
Wang H; Pei H; Ding W; Yang D; Ma L
J Thromb Thrombolysis; 2021 Feb; 51(2):397-404. PubMed ID: 32562101
[TBL] [Abstract][Full Text] [Related]
18. Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin.
Moaveni DK; Lynch EM; Luke C; Sood V; Upchurch GR; Wakefield TW; Henke PK
J Vasc Surg; 2008 Mar; 47(3):616-24. PubMed ID: 18295113
[TBL] [Abstract][Full Text] [Related]
19. Knowledge and practice of prophylaxis of deep venous thrombosis: A survey among Nigerian surgeons.
Kesieme EB; Arekhandia BJ; Inuwa IM; Akpayak IC; Ekpe EE; Olawoye OA; Umar A; Awunor NS; Amadi EC; Ofoegbu IJ
Niger J Clin Pract; 2016; 19(2):170-4. PubMed ID: 26856276
[TBL] [Abstract][Full Text] [Related]
20. Deep vein thrombosis prophylaxis: Are we overdoing? An Asian survey on trends in bariatric surgery with a systematic review of literature.
Bhattacharya S; Kumar SS; Swamy PDK; Palanivelu C; Raj PP
J Minim Access Surg; 2018; 14(4):285-290. PubMed ID: 29226883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
